Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial.
about
Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT).Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study.Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models.The potential role of platelets in the consensus molecular subtypes of colorectal cancer.Neoadjuvant chemotherapy affects molecular classification of colorectal tumors.CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models.Lifestyle, Diet, and Colorectal Cancer Risk According to (Epi)genetic Instability: Current Evidence and Future Directions of Molecular Pathological Epidemiology.Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models.Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.polyClustR: defining communities of reconciled cancer subtypes with biological and prognostic significance.Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutationsPrognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer
P2860
Q33576805-FDC4773B-223D-4468-BC1B-363CEBC3F890Q33608167-11A86969-5E80-4A0F-B9E8-C64C99AA84C4Q39184305-D74011F5-50E2-4730-BF64-3CCE9D6E48BAQ39417307-CC4C5C8E-8D3E-487A-A38F-C37115CF0D13Q41228722-07D427E0-6AF9-4747-9421-E4DDBE2B2F3FQ47104672-FD3636C4-AE12-49B8-9C32-994DC492E0A6Q47138060-22479D07-67B5-4790-8E5B-A2E1D3916539Q47203432-967D6B11-90E2-4B5E-B3AD-1B1F7EB134EDQ48229350-FD2EA9CF-3E9F-4BDB-8EFE-80AC3CCB1F71Q55311987-3CA6A5AD-CDAC-4EB9-8452-80165C1670B8Q58771752-A35D0A71-2ABD-41E4-85FC-1294769D36A2Q58776529-BD2ECD39-9903-4734-8A74-2E7E9829862E
P2860
Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Clinical Outcome From Oxalipla ...... ogy Randomized Clinical Trial.
@en
type
label
Clinical Outcome From Oxalipla ...... ogy Randomized Clinical Trial.
@en
prefLabel
Clinical Outcome From Oxalipla ...... ogy Randomized Clinical Trial.
@en
P2093
P2860
P1433
P1476
Clinical Outcome From Oxalipla ...... logy Randomized Clinical Trial
@en
P2093
Carmen J Allegra
Corey Lipchik
Greg Yothers
Katherine L Pogue-Geile
Michael J O'Connell
Nicholas J Petrelli
Nicole L Johnson
Norman Wolmark
P2860
P304
P356
10.1001/JAMAONCOL.2016.2314
P577
2016-09-01T00:00:00Z